| Tag | Content |
|---|
EnhancerAtlas ID | HS139-20618 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr16:27386250-27386750 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFYA | MA0060.3 | chr16:27386564-27386575 | GGCCAATCAGA | + | 6.02 | | NFYB | MA0502.1 | chr16:27386624-27386639 | AAACTGACCAATGAG | + | 6.2 | | Stat6 | MA0520.1 | chr16:27386486-27386501 | CAGTTCCAGAGAACT | + | 7.07 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09427 | chr16:27384545-27387300 | CD14 | | SE_17448 | chr16:27383584-27387027 | CD4p_CD25-_CD45RAp_Naive | | SE_18369 | chr16:27385023-27386916 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_32588 | chr16:27383754-27387820 | GM12878 | | SE_58873 | chr16:27377779-27444663 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I027372 | chr16 | 27383747 | 27387314 |
|
Enhancer Sequence | CCTGACCCCT CTAGACACCA TCATCTGACT ACACGCCACC ACCCAGCCAC AGTTCCCAGC 60
CCACACCATG CAATTTCAAC CTCCAAGCCT TTTCTCATGC CTTTCCCTCT GGCAGGCACG 120
CCCCTCCCTA CCACTCTTCC GGACGAACCC GGCTATCCTG CCTGCCCTGT ATCTACTCTC 180
CCTTCTTCTG ACATCACCAC CTGGTGGTCC TTGCCGGGAC AGCGTCTTCC CACTCGCAGT 240
TCCAGAGAAC TGATCTAACT GCCAGAGAAC TGATCTAACT CCTAGCTTTC CAACAGGGCA 300
CATGACTCAG GCTTGGCCAA TCAGAGCATT CCTTTCCCAA TCTGAAGATT GGTTCAGGGA 360
CAGGCATATG ATTAAAACTG ACCAATGAGA GCTTTTCCTG GTAGCATCAT TGGAACCATT 420
AGGAAAACAT GCCTTCTTTC CTTTGGGCTT TGAAAGCTGG TAGGTGGTAG GTCTTGGCTT 480
CTGAGGTCCC TGCTTTTCTT 500
|
